|
AUPH Aurinia Pharmaceuticals Inc 1600620 |
| Balance Sheet |
|
Current Assets
|
$541,324,000.00 |
|
Assets
|
$792,262,000.00 |
|
Current Liabilities
|
$99,893,000.00 |
|
Liabilities
|
$177,398,000.00 |
|
Equity
|
$614,864,000.00 |
|
Shares Out
|
132907000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$85,126,000.00 |
|
Investing Cash Flow
|
$63,368,000.00 |
| Market Analysis |
Market Cap
|
$2,295,303,890.00 |
|
Price
|
$16.90 |
|
BVPS
|
4.63 |
|
PB
|
3.73 |
|
EPS
|
0.29 |
|
PE
|
7.95 |
|
PS
|
6.90 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:20 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
1.53 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
0.25 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
0.16 |
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
0.23 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AUPH documents filed with the SEC.
AUPH Filings
Clear
